FOMAT

Follow us:

Cancer Clinical Trials in California

FOMAT Medical is enrolling patients with lung cancer, colorectal cancer, and metastatic cancer at our California research unit. Participation is free, and you may be compensated for your time.

cancer clinical trials California FOMAT Medical

An option worth knowing about

Cancer clinical trials in California are open right now at FOMAT Medical. Most people with a diagnosis focus on what their doctor already recommends. That makes sense. But most patients never think to ask about this option.

At FOMAT Medical’s California research unit, you get access to investigational treatments before they reach the general market. Your care is covered. And you are compensated for your time. You can learn more about how clinical trials work at cancer.org.

What We Research

Our cancer clinical trials in California focus on three areas:

Lung cancer
We work with patients diagnosed with non-small cell lung cancer and small cell lung cancer. This includes studies targeting specific mutations like EGFR and KRAS. If standard treatment has not worked the way you hoped, there may be a study here for you.

Colorectal cancer
New investigational therapies for advanced and treatment-resistant colorectal cancer are becoming available faster than ever. Trial participants get access before anyone else does.

Metastatic cancer
If your cancer has spread, you may still qualify. FDA guidelines now allow broader eligibility for patients with advanced disease, including those with brain metastases.

You can browse our active studies to see what is currently open

cancer clinical trials California FOMAT Medical
Cancer Clinical Trials | FOMAT

Frequently asked questions about oncology clinical trials

Can I join a cancer clinical trial if I have already received chemotherapy or radiation?

 Yes, in many cases. Most oncology trials at FOMAT Medical are designed for patients who have already undergone standard treatment. Some studies specifically seek participants who have completed first- or second-line therapy. Your prior treatment history is reviewed during pre-screening to determine which studies you may be eligible for.

Each study has its own inclusion criteria and exclusion criteria, which are medical rules that define who can safely take part. These can include age, diagnosis, lab results or other health conditions. The research team reviews these details with you and lets you know if a study is a good match.

FOMAT’s California oncology unit conducts trials for both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including studies targeting specific genetic mutations. Eligibility depends on your cancer subtype, stage, and treatment history. Contact our team or complete the pre-screening form to find out which studies are currently open.

Yes. FOMAT conducts colorectal cancer trials at our California research unit, including studies for patients with advanced or treatment-resistant disease. If you have a confirmed colorectal cancer diagnosis and are seeking additional treatment options, you may be eligible to participate.

No. All study-related care, including visits, lab work, imaging, and investigational medication, is provided at no cost. Participants are also compensated for their time and travel. You do not need insurance to participate.

Yes. Participation in a FOMAT clinical trial does not replace your existing oncology care. We coordinate with your treating physician and keep them informed throughout the study. Your standard care continues in parallel.

Participation is always voluntary. You may withdraw from a FOMAT oncology trial at any time, for any reason, without penalty or impact on your access to other medical care. Our team will guide you through a safe exit process.

Read real patient stories and see if a clinical trial could be right for you